Press release
Evolving Market Trends In The Autacoids And Related Drug Industry: Improving Access To Allergy Medications Through OTC Availability
Autacoids And Related Drug
_x000D_
What Is the Expected Autacoids And Related Drug Market Size During the Forecast Period?_x000D_
There has been a remarkable growth in the market size of autacoids and analogous drugs in the previous years. It is set to escalate from $50.15 billion in 2024 to $53.32 billion in 2025, portraying a compound annual growth rate (CAGR) of 6.3%. The growth exhibited during the historical period owes its credit to several factors; a rise in the occurrence of inflammatory diseases, increased use of prostaglandins in the field of obstetrics, prevalent prescription of antihistamines, emerging uses of serotonin agonists and an escalated demand for medication to alleviate migraines._x000D_
_x000D_
Expectations are high that the autacoids and related drug market will witness robust growth in the forthcoming years. A growth spike anticipated to hit $67.64 billion by 2029, with a compound annual growth rate (CAGR) of 6.1%. Various factors that contribute to this growth during the forecast period include an increasing elderly population, the rising instances of chronic respiratory conditions, the acceptance of personalized medicine, developing healthcare facilities in emerging economies, and growing cardiovascular disorder rates. Key trends forecasted for this period consist of the inclusion of artificial intelligence in drug discovery, the advancement of dual-action autacoid drugs, the utilization of biosimilars for autacoid treatments, rise in self-medication and over-the-counter products, and the application of nanotechnology in drug formulation._x000D_
_x000D_
Purchase the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=24159&type=smp_x000D_
_x000D_
What Are the High-Growth Segments in the Autacoids And Related Drug Market?_x000D_
The autacoids and related drug market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin_x000D_
2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation_x000D_
3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders_x000D_
4) By End User: Hospitals, Clinics, Homecare, Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists_x000D_
2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs_x000D_
3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors_x000D_
4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators_x000D_
5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists_x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp_x000D_
_x000D_
What Key Drivers Are Expected to Influence Future Autacoids And Related Drug Market Growth?_x000D_
The rise in cardiovascular disorders is anticipated to fuel the expansion of the autacoids and related drugs market. Cardiovascular diseases are a collection of disorders affecting the heart and blood vessels, encompassing conditions like coronary heart disease, heart failure, stroke, and hypertension. The rise in these diseases is mainly due to poor dietary habits, particularly the overconsumption of saturated fats, trans fats, added sugars, and sodium, leading to high blood pressure, obesity, and high cholesterol levels- all significant risk factors for heart diseases. Autacoids and related drugs improve heart health by adjusting vascular tone and inflammation, which are critical in situations like hypertension and heart failure. Drugs that target nitric oxide, endothelin, and prostacyclin pathways aid in reinstating endothelial function, promoting vasodilation and lessening vascular resistance. Take, for instance, in December 2023, the Australian Institute of Health and Welfare, a government entity based in Australia, stated that doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022 in Australia. Consequently, the increasing occurrences of cardiovascular diseases are supporting the growth of the autacoids and related drugs market._x000D_
_x000D_
Which Companies Hold the Largest Share Across Different Autacoids And Related Drug Market Segments?_x000D_
Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc._x000D_
_x000D_
What Are the Latest Developing Trends in the Autacoids And Related Drug Market?_x000D_
Leading companies in the autacoids and related drugs market are prioritizing the development of pioneering products like antihistamines with the aim to improve therapeutic effectiveness, minimize adverse reactions, and accurately and safely treat emerging allergic and inflammatory diseases. Antihistamines perform by hindering the impacts of histamine, a chemical that the immune system discharges during an allergy flare-up. For example, Tiefenbacher Pharmaceuticals, a pharmaceutical firm based in Germany, introduced Bilastine as an over-the-counter remedy in Germany in March 2023. This breakthrough significantly enhances the accessibility of efficient allergy medications. Bilastine, a 20 mg tablet, provides a second-generation, non-sedating antihistamine solution for patients dealing with allergic reactions like hay fever and urticaria._x000D_
_x000D_
Get the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/report/autacoids-and-related-drug-global-market-report_x000D_
_x000D_
What Are the Emerging Geographies for The Autacoids And Related Drug Market Growth?_x000D_
North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
Frequently Asked Questions:_x000D_
1. What Is the Market Size and Growth Rate of the Autacoids And Related Drug Market?_x000D_
2. What is the CAGR expected in the Autacoids And Related Drug Market?_x000D_
3. What Are the Key Innovations Transforming the Autacoids And Related Drug Industry?_x000D_
4. Which Region Is Leading the Autacoids And Related Drug Market?_x000D_
_x000D_
Why This Report Matters:_x000D_
_x000D_
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors._x000D_
_x000D_
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends._x000D_
_x000D_
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Evolving Market Trends In The Autacoids And Related Drug Industry: Improving Access To Allergy Medications Through OTC Availability here
News-ID: 4060503 • Views: …
More Releases from The Business Research Company
Autoimmune Monoclonal Antibody Market Size Forecasted To Achieve 98.81 Billion B …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Autoimmune Monoclonal Antibody Market Size and Projected Growth Rate?
Recent years have seen robust growth in the autoimmune monoclonal antibody market. Currently valued at $65.83 billion in 2024, it's projected to expand to $71.71 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.7%. This marked progression in the…
The Growing Prevalence Of Chronic Illnesses Is Fueling The Growth Of The Market …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Expected Peptide Drug Conjugates Market Size During the Forecast Period?
In recent times, there has been a swift expansion in the size of the peptide drug conjugates market. It's projected that this market will escalate from a worth of $3.16 billion in 2024, to reach $3.68 billion in 2025, at a…
The Increasing Use Of Targeted Therapies Is Fueling The Market Growth Due To Enh …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics._x000D_
_x000D_
What Is the Expected Cytokine Release Syndrome Management Market Size During the Forecast Period?_x000D_
In the recent past, the market size for managing cytokine release syndrome has robustly expanded. It is projected to increase from a valuation of $22.32 billion in 2024 to about $23.83 billion in 2025, demonstrating a compound annual growth rate…
The Increasing Prevalence Of Infections Is Fueling The Market Growth Due To Risi …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Atypical Mycobacteriosis Treatment Market Size and Projected Growth Rate?
The market for treating atypical mycobacteriosis has seen robust growth in the recent past. The market is projected to expand from $2.26 billion in 2024 to $2.40 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.2%. The significant growth…
More Releases for Autacoids
Autacoids and Related Drugs Market Overview by Recent Opportunities, Growth Size …
The global autacoids and related drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Autacoids are defined as the biological elements that work similar to hormones and are permeated by the body cells in response to various types of stimulations. The simulations are carried out to prompt physiological responses such as treatment of a local injury or other ailments. Any discrepancy in the synthesis,…
Autacoids and Related Drugs Market to Witness Exponential Growth by 2024
Global Autacoids and Related Drugs Market: Overview
Autacoids refer to the biological factors that work like hormones and are released from body cells in response to various types of stimulations to prompt physiological responses such as treatment of a local injury or other ailments. Any imbalance in the release, synthesis, or transduction system associated with these temporarily formed biological agents trigger pathological conditions such as allergy, inflammation, and hypersensitivity. Autacoids antagonists…
Global Autacoids and Related Drugs Market Anticipated for Progressive CAGR Growt …
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global Autacoids and Related Drugs Market Size, Status and Forecast 2025” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the market for Autacoids and Related Drugs would rise at a positive…
Autacoids and Related Drugs Market Value Projected To Expand By 2024
Autacoids refer to the biological factors that work like hormones and are released from body cells in response to various types of stimulations to prompt physiological responses such as treatment of a local injury or other ailments. Any imbalance in the release, synthesis, or transduction system associated with these temporarily formed biological agents trigger pathological conditions such as allergy, inflammation, and hypersensitivity. Autacoids antagonists are prescribed for the prevention of…
Autacoids and Related Drugs Market by Global Trends & outlook
HTF MI published a new industry research that focuses on Autacoids and Related Drugs market and delivers in-depth market analysis and future prospects of Global Autacoids and Related Drugs market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market…
Autacoids and Related Drugs Market share will expand till 2024
Global Autacoids and Related Drugs Market: Overview
Autacoids refer to the biological factors that work like hormones and are released from body cells in response to various types of stimulations to prompt physiological responses such as treatment of a local injury or other ailments. Any imbalance in the release, synthesis, or transduction system associated with these temporarily formed biological agents trigger pathological conditions such as allergy, inflammation, and hypersensitivity. Autacoids antagonists…
